These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
583 related articles for article (PubMed ID: 8977633)
21. The synthetic estrogen diethylstilbestrol (DES) inhibits the telomerase activity and gene expression of prostate cancer cells. Geier R; Adler S; Rashid G; Klein A Prostate; 2010 Sep; 70(12):1307-12. PubMed ID: 20623632 [TBL] [Abstract][Full Text] [Related]
22. 5alpha-androstane-3alpha,17beta-diol supports human prostate cancer cell survival and proliferation through androgen receptor-independent signaling pathways: implication of androgen-independent prostate cancer progression. Yang Q; Titus MA; Fung KM; Lin HK J Cell Biochem; 2008 Aug; 104(5):1612-24. PubMed ID: 18320593 [TBL] [Abstract][Full Text] [Related]
23. NE-10 neuroendocrine cancer promotes the LNCaP xenograft growth in castrated mice. Jin RJ; Wang Y; Masumori N; Ishii K; Tsukamoto T; Shappell SB; Hayward SW; Kasper S; Matusik RJ Cancer Res; 2004 Aug; 64(15):5489-95. PubMed ID: 15289359 [TBL] [Abstract][Full Text] [Related]
24. Prosaposin is an AR-target gene and its neurotrophic domain upregulates AR expression and activity in prostate stromal cells. Koochekpour S; Lee TJ; Sun Y; Hu S; Grabowski GA; Liu Z; Garay J J Cell Biochem; 2008 Aug; 104(6):2272-85. PubMed ID: 18481277 [TBL] [Abstract][Full Text] [Related]
25. TabBO: a model reflecting common molecular features of androgen-independent prostate cancer. Navone NM; Rodriquez-Vargas MC; Benedict WF; Troncoso P; McDonnell TJ; Zhou JH; Luthra R; Logothetis CJ Clin Cancer Res; 2000 Mar; 6(3):1190-7. PubMed ID: 10741751 [TBL] [Abstract][Full Text] [Related]
26. Castration-induced increases in insulin-like growth factor-binding protein 2 promotes proliferation of androgen-independent human prostate LNCaP tumors. Kiyama S; Morrison K; Zellweger T; Akbari M; Cox M; Yu D; Miyake H; Gleave ME Cancer Res; 2003 Jul; 63(13):3575-84. PubMed ID: 12839944 [TBL] [Abstract][Full Text] [Related]
27. Acceleration of human prostate cancer growth in vivo by factors produced by prostate and bone fibroblasts. Gleave M; Hsieh JT; Gao CA; von Eschenbach AC; Chung LW Cancer Res; 1991 Jul; 51(14):3753-61. PubMed ID: 1712249 [TBL] [Abstract][Full Text] [Related]
28. Atlas of dihydrotestosterone actions on the transcriptome of prostate in vivo. Ma C; Yoshioka M; Boivin A; Gan L; Takase Y; Labrie F; St-Amand J Prostate; 2009 Feb; 69(3):293-316. PubMed ID: 19023869 [TBL] [Abstract][Full Text] [Related]
29. Analysis of vitamin D-regulated gene expression in LNCaP human prostate cancer cells using cDNA microarrays. Krishnan AV; Shinghal R; Raghavachari N; Brooks JD; Peehl DM; Feldman D Prostate; 2004 May; 59(3):243-51. PubMed ID: 15042599 [TBL] [Abstract][Full Text] [Related]
30. Regulation of global gene expression in the bone marrow microenvironment by androgen: androgen ablation increases insulin-like growth factor binding protein-5 expression. Xu C; Graf LF; Fazli L; Coleman IM; Mauldin DE; Li D; Nelson PS; Gleave M; Plymate SR; Cox ME; Torok-Storb BJ; Knudsen BS Prostate; 2007 Nov; 67(15):1621-9. PubMed ID: 17823924 [TBL] [Abstract][Full Text] [Related]
31. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1. Zaia A; Fraizer GC; Piantanelli L; Saunders GF Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720 [TBL] [Abstract][Full Text] [Related]
32. Pharmacologic basis for the enhanced efficacy of dutasteride against prostatic cancers. Xu Y; Dalrymple SL; Becker RE; Denmeade SR; Isaacs JT Clin Cancer Res; 2006 Jul; 12(13):4072-9. PubMed ID: 16818707 [TBL] [Abstract][Full Text] [Related]
33. Suppression of LNCaP prostate cancer xenograft tumors by a prostate-specific protein tyrosine phosphatase, prostatic acid phosphatase. Igawa T; Lin FF; Rao P; Lin MF Prostate; 2003 Jun; 55(4):247-58. PubMed ID: 12712404 [TBL] [Abstract][Full Text] [Related]
34. Prosaposin is a novel androgen-regulated gene in prostate cancer cell line LNCaP. Koochekpour S; Lee TJ; Wang R; Sun Y; Delorme N; Hiraiwa M; Grabowski GA; Culig Z; Minokadeh A J Cell Biochem; 2007 Jun; 101(3):631-41. PubMed ID: 17171640 [TBL] [Abstract][Full Text] [Related]
35. Interleukin-4 stimulates androgen-independent growth in LNCaP human prostate cancer cells. Lee SO; Pinder E; Chun JY; Lou W; Sun M; Gao AC Prostate; 2008 Jan; 68(1):85-91. PubMed ID: 18008330 [TBL] [Abstract][Full Text] [Related]
36. Androgens regulate vascular endothelial growth factor content in normal and malignant prostatic tissue. Joseph IB; Nelson JB; Denmeade SR; Isaacs JT Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2507-11. PubMed ID: 9815654 [TBL] [Abstract][Full Text] [Related]
37. The TRPS1 transcription factor: androgenic regulation in prostate cancer and high expression in breast cancer. Chang GT; Jhamai M; van Weerden WM; Jenster G; Brinkmann AO Endocr Relat Cancer; 2004 Dec; 11(4):815-22. PubMed ID: 15613454 [TBL] [Abstract][Full Text] [Related]
38. The conventional transforming growth factor-beta (TGF-beta) receptor type I is not required for TGF-beta 1 signaling in a human prostate cancer cell line, LNCaP. Kim IY; Zelner DJ; Lee C Exp Cell Res; 1998 May; 241(1):151-60. PubMed ID: 9633523 [TBL] [Abstract][Full Text] [Related]
39. Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts. Fizazi K; Yang J; Peleg S; Sikes CR; Kreimann EL; Daliani D; Olive M; Raymond KA; Janus TJ; Logothetis CJ; Karsenty G; Navone NM Clin Cancer Res; 2003 Jul; 9(7):2587-97. PubMed ID: 12855635 [TBL] [Abstract][Full Text] [Related]
40. Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells. Arnold JT; Le H; McFann KK; Blackman MR Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E573-84. PubMed ID: 15536203 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]